1 completed, 1 not yet recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Intravenous: new trials by email Literature Review of Intravenous trials Research Report on Intravenous
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multicenter Phase II Trial of NRICM102 Combined With Standard Therapy in Pneumonia NRICM102, Placebo, Intravenous Antibiotic - Mild to Moderate, Community-Acquired Pneumonia (CAP) | Phase 2 | Not yet recruiting | National Research Institute of Chinese Medicine, Ministry of Health and Welfare | 150 | 2026-06-01 | 2026-05-13 |
| Pharmacokinetics of Intraperitoneal and Intravenous Meropenem, Ampicillin, Aztreonam and Ciprofloxacin in Automated Peritoneal Dialysis Patients Without Peritonitis Application of intraperitoneal and intravenous meropenem in in automated peritoneal dialysis patients without peritonitis, Application of intraperitoneal and intravenous ampicillin in automated peritoneal dialysis patients without peritonitis, Application of intraperitoneal and intravenous aztreonam in automated peritoneal dialysis patients without peritonitis - Peritoneal Dialysis-associated Peritonitis, Peritoneal Dialysis (PD) | Phase 2 / Phase 3 | Completed | Karl Landsteiner Insitute for Nephrology and Haemato-Oncology | 24 | 2014-04-08 | 2025-08-14 |
Community-Acquired Pneumonia (1)
Community-Acquired Infections (1) · Infections (1) · Pneumonia (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
Karl Landsteiner Insitute for Nephrology and Haemato-Oncology (1) · National Research Institute of Chinese Medicine, Ministry of Health and Welfare (1)
Austria (1) · Taiwan (1)